Cost-Effective Generics Putney focuses on developing high quality generic medicines for pets where cost is a barrier, presenting a clear upsell opportunity to veterinary practices seeking affordable, reliable alternatives to expensive brand-name drugs.

Vet Partnership Model The company emphasizes partnering with veterinary practices to improve margins and grow their clinics, suggesting collaborative sales strategies such as co-branding, education programs, and trusted supply arrangements to drive adoption.

U.S. Veterinary Focus Customer priority is U.S. veterinarians treating dogs and cats, indicating sales motions should target American clinics with alignment to local regulatory and purchasing cycles and tailoring to common companion animal treatments.

Education and Choice Putney commits to educating vets to evaluate best treatments, presenting an opportunity to offer continuing education, clinical support materials, and decision-support tools that position their generics as preferred options.

Growth Readiness With moderate revenue and a growing investor footprint, there is potential for scalable partnerships, channel expansion, and upgraded sourcing/supply capabilities that can attract larger veterinary distributors and practices seeking reliability and cost efficiency.